{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T04:40:37Z","timestamp":1758343237195,"version":"3.44.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Mild traumatic brain injury (mTBI) has been termed the signature wound of active duty service members (ADSM) returning from Operation Iraqi Freedom and Operation Enduring Freedom with estimated incidence rates between 19.5% and 23%, respectively. Locally, mTBI accounted for 9% of all diagnoses at Fort Bragg, NC, between 2016 and 2022. Our study examines long-term effects of medications prescribed to reduce or prevent mTBI complications that may lead to postconcussive syndrome (PCS).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The Medical Assessment and Readiness System (MARS) housed at Womack Army Medical Center, Fort Bragg, NC was used to capture unique health care encounters including ICD-10 codes for concussion or mTBI from 2016-2022. The overarching MARS protocol (17-02683) was approved by the Naval Medical Center Portsmouth Institutional Review Board in compliance with all applicable Federal regulations governing the protection of human subjects. We identified ADSMs receiving initial outpatient treatment for concussion. Each SM had a concurrent active prescription before the initial injury diagnosis or received a prescription for one or more prophylactic drug candidates on the day of mTBI diagnosis. Our analysis included therapeutics prescribed at the time of injury used to treat conditions unrelated to TBI. We stratified to include concurrent prescription data and assess prevalence of primary (short term) and secondary (long term) mTBI symptoms and sequelae including PCS constellation symptoms associated with prescription use.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We analyzed 46,691 unique outpatient encounters for ADSMs initially receiving outpatient treatment for concussion from 2016 to 2022 generating a convenience sample of 2,638 SMs with an existing prescription, or who were prescribed PDC at the time of mTBI diagnosis. Our convenience sample experienced triple the rate of migraine diagnosis (ICD10: G43, 33% and 31%) and sleep disorders (ICD10: G47; 57% and 62%) within 2 years post mTBI when compared to controls with no PDC prescription. Post-traumatic headache (ICD10: G443) rates doubled from 15.5% in controls with no prescription to 30% and 31% in ADSMs with prescriptions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Secondary injury mechanisms may expand mTBI, leading to increased neuronal death and injury expansion. However, clinical attempts to mitigate tissue damage may result in long-term effects that increase PCS symptom severity, resulting in a reduction of ADSMs\u2019 overall health, well-being, and readiness. Our findings suggest increased negative health risks following use of specific prescription drugs for mTBI. Additional prospective trials are required to identify viable mitigation strategies.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/milmed\/usaf195","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T22:22:21Z","timestamp":1758320541000},"page":"363-370","source":"Crossref","is-referenced-by-count":0,"title":["Exposome Signatures of Prescription Medication and Mild Traumatic Brain Injury Sequelae"],"prefix":"10.1093","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0375-3350","authenticated-orcid":false,"given":"Jessica A","family":"White-Phillip","sequence":"first","affiliation":[{"name":"Department of Clinical Investigation, Womack Army Medical Center , Fort Bragg, NC 28310,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A","family":"Beltran","sequence":"additional","affiliation":[{"name":"Department of Clinical Investigation, Womack Army Medical Center , Fort Bragg, NC 28310,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7484-9942","authenticated-orcid":false,"given":"Carlos J","family":"Maldonado","sequence":"additional","affiliation":[{"name":"Department of Clinical Investigation, Womack Army Medical Center , Fort Bragg, NC 28310,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"issue":"1","key":"2025091919345863400_R1","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-021-00363-y","article-title":"Military traumatic brain injury: a challenge straddling neurology and psychiatry","volume":"9","author":"Kong","year":"2022","journal-title":"Military Med Res"},{"author":"Armed Forces Health Surveillance Division","key":"2025091919345863400_R2","article-title":"DoD numbers for traumatic brain injury worldwide totals \u2013 2022"},{"issue":"5","key":"2025091919345863400_R3","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1097\/TA.0b013e3181d8956d","article-title":"Neurological effects of blast injury","volume":"68","author":"Hicks","year":"2010","journal-title":"J Trauma"},{"issue":"6","key":"2025091919345863400_R4","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1089\/neu.2007.0484","article-title":"Explosive blast neurotrauma","volume":"26","author":"Ling","year":"2009","journal-title":"J Neurotrauma"},{"issue":"2","key":"2025091919345863400_R5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.48150","article-title":"Association of traumatic brain injury with mortality among military veterans serving after September 11, 2001","volume":"5","author":"Howard","year":"2022","journal-title":"JAMA Network Open"},{"author":"DOD Instruction 1332.45","key":"2025091919345863400_R6","article-title":"Retention determinations for non-deployable service members, office of the under secretary of defense for personnel and readiness"},{"issue":"1","key":"2025091919345863400_R7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/ije\/dyr236","article-title":"The exposome: from concept to utility","volume":"41","author":"Wild","year":"2012","journal-title":"Int J Epidemiol"},{"volume-title":"Stata Statistical Software: Release 17","year":"2019","author":"StataCorp","key":"2025091919345863400_R8"},{"key":"2025091919345863400_R9","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.635483","article-title":"Drug repurposing in the treatment of traumatic brain injury","volume":"15","author":"Ghiam","year":"2021","journal-title":"Front Neurosci"},{"issue":"7","key":"2025091919345863400_R10","doi-asserted-by":"publisher","DOI":"10.3390\/ph15070838","article-title":"Current and potential pharmacologic therapies for traumatic brain injury","volume":"15","author":"Tani","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"1","key":"2025091919345863400_R11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054163","article-title":"Amelioration of acute sequelae of blast induced mild traumatic brain injury by N-acetyl cysteine: a double-blind, placebo controlled study","volume":"8","author":"Hoffer","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"2025091919345863400_R12","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1007\/s13311-023-01426-9","article-title":"Treating traumatic brain injury with minocycline","volume":"20","author":"Bergold","year":"2023","journal-title":"Neurotherapeutics"},{"issue":"6","key":"2025091919345863400_R13","doi-asserted-by":"publisher","DOI":"10.1111\/head.14529","article-title":"Randomized controlled pilot trial of prazosin for prophylaxis of posttraumatic headaches in active-duty service members and veterans","volume":"63","author":"Mayer","year":"2023","journal-title":"Headache"},{"journal-title":"Joint Trauma System Clinical Practice Guideline (JTS CPG).","article-title":"Traumatic Brain injury Management in Prolonged Field Care","author":"van Wyck","key":"2025091919345863400_R14"},{"issue":"1","key":"2025091919345863400_R15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003468","article-title":"Amantadine in Parkinson\u2019s disease","volume":"2003","author":"Crosby","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2025091919345863400_R16","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/CORR.0000000000001642","article-title":"How common are civilian blast injuries in the National Trauma Databank, and what are the most common mechanisms and characteristics of associated injuries?","volume":"479","author":"Nunziato","year":"2021","journal-title":"Clin Orthop Relat Res"},{"issue":"3-4","key":"2025091919345863400_R17","doi-asserted-by":"publisher","first-page":"e795","DOI":"10.1093\/milmed\/usad378","article-title":"Combat deployed service members by blast TBI and service separation status 5-years post-deployment: comparison of cognitive, neurobehavioral, and psychological profiles of those who left vs. those still serving","volume":"189","author":"Coppel","year":"2024","journal-title":"Mil Med"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/190\/Supplement_2\/363\/64288183\/usaf195.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/190\/Supplement_2\/363\/64288183\/usaf195.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T23:35:04Z","timestamp":1758324904000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/190\/Supplement_2\/363\/8256313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":17,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2025,9,16]]},"published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/milmed\/usaf195","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"type":"print","value":"0026-4075"},{"type":"electronic","value":"1930-613X"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,9,1]]}}}